跳至主要内容
临床试验/NCT06527079
NCT06527079尚未招募不适用

Evaluation of Clinical Decision Support in Opioid Tapering

University of Colorado, Denver0 个研究点目标入组 200,000 人开始时间: 2026年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
200,000
主要终点
Percentage of encounters tapering within CDC guidelines

研究概览

简要总结

The 2022 Center for Disease Control and Prevention (CDC) clinical practice guideline for prescribing opioids for pain recommends that when tapering a patient's opioid dose, doses should be decreased at a slow rate to reduce the risk of withdrawal symptoms, overdose, and to promote tolerance of the tapering. This project will evaluate a clinical decision support (CDS) tool in the form of a clinical care pathway that gives providers information, recommendations, and educational material on strategies for opioid tapering. Primary care providers will be randomized at the clinic location to a control arm or intervention arm. The control arm will have the clinical care pathway available, but will not be reminded of the pathway when tapering a patient. The intervention arm will receive a nudge when prescribing a tapering opioid strategy to a patient to use the clinical care pathway. The rate of opioid tapering in line with CDC guidelines will be examined as well as long-term patient outcomes of opioid overdose or poisoning using existing patient health records. The study period will be approximately 18 months.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 89 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary care patients being tapered from an opioid. Tapering patients:
  • Have an active opioid prescription for more than 3 months and
  • Prescribed more than 90 morphine milligram equivalents (MME) per day or
  • Co-prescribed an opioid and benzodiazepine or
  • Received a reduction in opioid dosage by more than 5% MME per day

排除标准

  • Patients <12 and >89
  • Patients with active cancer diagnosis in last 1 year
  • Patients with hospice care/palliative care order
  • Patients with sickle cell disease diagnosis

结局指标

主要结局

Percentage of encounters tapering within CDC guidelines

时间窗: 18 months

The number of encounters where a provider's actions are in line with CDC tapering guidelines divided by the total number of opioid tapering prescriptions

次要结局

  • Subsequent opioid overdose/poisoning rates(6 months after taper encounter)
  • Health care utilization(6 months after taper encounter)
  • Clinical decision support (CDS) acceptance rate(18 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验